Drugs Made In America Acquisition II Corp.
DMII- Exchange
- Nasdaq
- Industry
- Blank Checks
- SEC CIK
- 0002040475
No open-market purchases or sales by Drugs Made In America Acquisition II Corp. insiders were filed in the last 90 days; 69 institutions reported holding it in 13F filings for Q2 2026, worth $457.4M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Drugs Made In America Acquisition II Corp. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Q1 2026 | Change |
|---|---|---|---|
| Holders | 51 | 68 | +17 |
| Shares | 34.7M | 43.9M | +9.20M (+26.5%) |
| Value | $342.9M | $438.1M | +$95.2M (+27.8%) |
New holders (19)
Institutions that held Drugs Made In America Acquisition II Corp. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| MMCAP International Inc. SPC | 2,700,000 | $26.9M | 2.32% |
| Healthcare of Ontario Pension Plan Trust Fund | 2,000,000 | $20.0M | 0.03% |
| Mercuria Capital Strategies, LLC | 750,000 | $7.48M | 2.86% |
| Heights Capital Management, Inc | 519,400 | $5.18M | 1.45% |
| BlueCrest Capital Management Ltd | 500,000 | $4.99M | 0.47% |
| Crossingbridge Advisors, LLC | 350,000 | $3.49M | 0.63% |
| Kryger Capital LLC | 309,729 | $3.09M | 0.22% |
| Rivernorth Capital Management, LLC | 300,000 | $2.99M | 0.15% |
| Highbridge Capital Management LLC | 225,004 | $2.25M | 0.14% |
| Gabelli & Co Investment Advisers, Inc. | 179,500 | $1.79M | 0.27% |
| Gabelli Funds LLC | 161,400 | $1.61M | 0.01% |
| Parallax Volatility Advisers, L.P. | 133,647 | $1.34M | 0.06% |
| Schonfeld Strategic Advisors LLC | 112,323 | $1.12M | 0.01% |
| Centiva Capital, LP | 100,000 | $998.0K | 0.05% |
| PenderFund Capital Management Ltd. | 49,700 | $496.0K | 0.08% |
| UBS Group AG | 44,735 | $446.0K | 0.00% |
| Limestone Investment Advisors LP | 11,900 | $118.6K | 0.06% |
| Logan Stone Capital, LLC | 11,313 | $112.8K | 0.03% |
| Robinson Capital Management, LLC | 10,000 | $100.1K | 0.04% |
Sold out (2)
Institutions that held Drugs Made In America Acquisition II Corp. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Cable Car Capital LLC | 100,000 | $990.0K |
| Quarry LP | 100,000 | $990.0K |